THERAtRAME

THERAtRAME was founded based on new insights in transfer RNA (tRNA) epitranscriptomics resulting from over a decade of fundamental research at the GIGA Institute (ULiège) and WELBIO.

Transfer RNAs mediate the translation of the genetic information (mRNAs) into cellular effectors (proteins). Chemical modifications of tRNA molecules promote cellular adaptation through reprogramming of protein expression, playing a key role in disease establishment, such as cancer.

The work of the company founders revealed that cancer cells seize control of the protein synthesis process by making specific modifications in the tRNA, an essential component of the protein translation machinery, to support the cells’ rapid growth, metastasis and resistance against existing drugs. This new discovery exposes previously underexplored vulnerabilities in cancer that are now being targeted by THERAtRAME’s drug discovery platform to develop first-in-class small molecule therapeutics to address the high unmet medical needs in cancer treatment.

In addition, THERAtRAME leverages its proprietary artificial intelligence algorithms to discover new unpredicted key players in cancer development and to identify the most promising oncology indications for clinical studies.

THERAtRAME raised €4.5M seed financing in September 2022.

Subscribe for alerts on new companies featured on Startups.Bio

Archon Biosciences
Archon Biosciences is a biotech company pioneering computationally designed 'Antibody Cages' to unlock powerful therapeutic targets beyond the reach of existing modalities. Archon directly applies generative protein design to rapidly …
Cytospire Therapeutics
Founded in 2023, Cytospire Therapeutics is developing a portfolio of next-generation immune cell engagers for treating cancer. The company's multispecific antibodies are designed to harness and direct the power of …
This Week in Biotech Venture Capital
The biotech sector continues to see a strong flow of new venture capital deals, with a flurry of new announcements this week. We saw a diverse set of companies—ranging from …
THRONCAT
THRONCAT is a new startup that aims to transform the field of protein analysis and mRNA therapeutics safety. THRONCAT began with a mission to make protein analysis more accessible and …

View all recently featured startups

Tags: